NICPLD issued correspondence yesterday advising that they will now be running two additional webinars on Experiential Learning (EL), due to recent demand.
SUMMARY
Experiential learning will involve students from Queen’s University and the University of Ulster undertaking a total of 12 week long placements in community, general practice and hospital settings, spread across their MPharm programme, 3 of which will be spent in a community pharmacy.
The placements will commence in participating community pharmacies in November 2023.
During their placements, students will be required to complete five designated learning activities, which should be overseen by an accredited pharmacist who has completed the necessary training to act as an EL “Practice Supervisor”.
Pharmacists acting as a Practice Supervisor are required to have been registered for a minimum of one year.
Contractors and pharmacists who are interested in offering EL will be provided with an overview and will be able to ask questions and/or express their interest at the end of the webinars.
Funding of £592 per week will be paid to Contractors providing EL placements at their pharmacies, with training and accreditation expenses also being allocated in 2022/23 for those pharmacists wishing to become Practice Supervisors.
Please ensure that your pharmacist(s) are made of aware of the webinars if you are considering becoming an EL provider at any of the pharmacy locations in which they work.
Please feel free to contact a member of the CPNI team should you have any questions, or alternatively queries can also be directed to NICPLD.
Kind regards
SENT ON BEHALF OF Gerard Greene Chief Executive
Dear Contractor
Please see attached correspondence from the Department of Health outlining the planning assumptions for a targeted spring 2023 COVID-19 vaccination booster programme, subject to the publication of the final JCVI advice.
SUMMARY
In summary, for planning purposes:
The Department is asking systems to plan to vaccinate the groups eligible last spring. This would include:
Adults aged 75 years and over
Residents in care homes
Individuals aged 5 years and over who are immunosuppressed, as defined in the Green Book (tables 3 and 4)
The spring booster programme is likely to start by mid-April and the spring booster offer will officially come to an end on the 30 June 2023.
The programme is expected to include those who turn 75 years old by 30 June 2023 who will be eligible for a vaccination at any point during the spring campaign.
Those who are admitted to an older adult care home or become immunosuppressed by 30 June 2023 should be considered eligible as well.
This advice may be updated upon receiving final JCVI advice. Following final JCVI advice, the Green Book will be updated.
Further guidance on the transition to a targeted primary course offer will be published in due course.
As with earlier stages of the COVID-19 vaccination programme, for the spring booster programme we expect all care homes to be paired with a community pharmacy who will attend the home and offer vaccination to all residents.
In addition to being invited by their own GP, those aged 75+ or immunocompromised individuals will also have the option to receive the vaccine via a participating community pharmacy.
There is expected to be sufficient supplies of COVID-19 vaccines to cover the eligible NI population of approximately 186,000 people.
ACTION
Contractors should read the attached correspondence to enable initial planning for the Spring COVID-19 Vaccination Booster Programme.
CPNI colleagues will continue to keep you up to date on any further Spring COVID-19 Vaccinations Booster Programme updates.
Return the monthly monitoring formfor February and March 2023 to the local SPPG office by the end of first week of the following month.
February monitoring form should be submitted by the end of the first week in March and March monitoring form should be submitted by the end of the first week in April.
The monthly monitoring form only requires details of NEW patients who have been commenced on adherence support in the month to which the form relates.
The information you need to include can be found HERE.
This is a transitional arrangement until 31 March 2023 and CPNI will be working closely with SPPG and DoH colleagues over the coming weeks to define the service from 1 April 2023 onwards.
Please do not hesitate to contact the CPNI office if you require any further information.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Colleague
The final update of concessionary prices were granted today for February 2023:
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter.
Concessionary prices are also published on the CPNI website.
Kind regards
SENT ON BEHALF OF GERARD GREENE
Chief Executive
Dear Contractor
SUMMARY
Correspondence has been issued by MRG in respect of Controlled Drug Declarations and Self-Assessments for 2023.
The format will remain as an online questionnaire and can be found at HERE.
The declaration and self-assessment should be completed no later than 31 March 2023. Details relating to completion of the questionnaire are contained in the link.
ACTION
Contractors should:
Note the requirement to complete a Controlled Drug Declaration and Self-Assessment by 31 March 2023.
You may be aware that the UK Commission on Pharmacy Professional Leadership published a report earlier this month, setting out a number of recommendations. The report is available here and a Webinar providing further information on the report and recommendations will take place on Wednesday 01 March 2023 at 7pm.
SUMMARY
The proposals include:
The establishment of a Pharmacy Leadership Council that fosters closer collaboration between professional leadership bodies and specialist professional groups and supports them in the implementation of the report’s vision and recommendations over five years.
ACTION
Contractors may wish to:
Read the Commission report which is available here.
Consider enrolling for the information Webinar which is taking place on Wednesday 01 March 2023 at 7pm, and make relevant team members aware.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
